Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
6,395 USD | -3,25% | -1,92% | +27,39% |
Attività
Numero di dipendenti: 628
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Richard Adcock
CEO | Chief Executive Officer | 55 | 01/10/20 |
Founder | 71 | 01/12/14 | |
David Sachs
DFI | Director of Finance/CFO | 46 | 01/03/21 |
Leonard Sender
COO | Chief Operating Officer | - | 01/03/20 |
John Lee
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/03/19 |
Sandeep K. Reddy
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/20 |
Hans Klingemann
CTO | Chief Tech/Sci/R&D Officer | 74 | - |
Enrique Dilone
CTO | Chief Tech/Sci/R&D Officer | 57 | 14/08/23 |
Barry Simon
BRD | Director/Board Member | 59 | 01/01/07 |
- | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Founder | 71 | 01/12/14 | |
Cheryl Cohen
BRD | Director/Board Member | 58 | 01/06/19 |
Wesley Clark
BRD | Director/Board Member | 78 | 01/03/21 |
Director/Board Member | 69 | 01/03/21 | |
Barry Simon
BRD | Director/Board Member | 59 | 01/01/07 |
Michael Blaszyk
BRD | Director/Board Member | 71 | 01/07/15 |
Richard Adcock
CEO | Chief Executive Officer | 55 | 01/10/20 |
John Brennan
BRD | Director/Board Member | 67 | 01/03/21 |
Linda Maxwell
BRD | Director/Board Member | 50 | 29/03/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 691 731 761 | 153 590 928 ( 22,20 %) | 163 800 ( 0,0237 %) | 22,20 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+27,39% | 4,44 Mrd | |
+11,91% | 118 Mrd | |
+11,60% | 106 Mrd | |
-4,68% | 24,28 Mrd | |
-0,82% | 21,96 Mrd | |
-10,12% | 18,16 Mrd | |
-42,12% | 16,37 Mrd | |
-17,47% | 15,56 Mrd | |
+2,77% | 13,63 Mrd | |
+34,58% | 12,27 Mrd |
- Borsa valori
- Azioni
- Azione IBRX
- Società ImmunityBio, Inc.